Join
Live feed
·
INSIDERFilingvia Quantisnow
KemPharm Inc. logo

SEC Form 4: Sangiovanni Timothy J. bought $4,967 worth of shares (1,200 units at $4.14), increasing direct ownership by 37% to 4,449 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KMPH (KemPharm Inc.) and more on Quantisnow.